Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Apr 28;300(6732):1132–1131. doi: 10.1136/bmj.300.6732.1132

Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.

E J Byrne 1, T Arie 1
PMCID: PMC1662815  PMID: 2160850

Full text

PDF
1132

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Byrne J., Arie T. Tetrahydroaminoacridine (THA) in Alzheimer's disease. BMJ. 1989 Apr 1;298(6677):845–846. doi: 10.1136/bmj.298.6677.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crook T. Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment. Psychopharmacol Bull. 1988;24(1):31–38. [PubMed] [Google Scholar]
  3. Helms P. M. Efficacy of antipsychotics in the treatment of the behavioral complications of dementia: a review of the literature. J Am Geriatr Soc. 1985 Mar;33(3):206–209. doi: 10.1111/j.1532-5415.1985.tb04894.x. [DOI] [PubMed] [Google Scholar]
  4. Leibovici A., Tariot P. N. Agitation associated with dementia: a systematic approach to treatment. Psychopharmacol Bull. 1988;24(1):49–53. [PubMed] [Google Scholar]
  5. Little A., Levy R., Chuaqui-Kidd P., Hand D. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):736–742. doi: 10.1136/jnnp.48.8.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Risse S. C., Barnes R. Pharmacologic treatment of agitation associated with dementia. J Am Geriatr Soc. 1986 May;34(5):368–376. doi: 10.1111/j.1532-5415.1986.tb04320.x. [DOI] [PubMed] [Google Scholar]
  7. Rossor M. N., Iversen L. L., Reynolds G. P., Mountjoy C. Q., Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) 1984 Mar 31;288(6422):961–964. doi: 10.1136/bmj.288.6422.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sahakian B., Jones G., Levy R., Gray J., Warburton D. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry. 1989 Jun;154:797–800. doi: 10.1192/bjp.154.6.797. [DOI] [PubMed] [Google Scholar]
  9. Wesseling H., Agoston S., Van Dam G. B., Pasma J., DeWit D. J., Havinga H. Effects of 4-aminopyridine in elderly patients with Alzheimer's disease. N Engl J Med. 1984 Apr 12;310(15):988–989. doi: 10.1056/NEJM198404123101514. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES